Therapeutic Guidelines - Psychotropic

Patient issues with psychiatric treatment
- Adherence (compliance) with psychotropic treatment
- Informed consent in mental illness
- Dependence, tolerance and withdrawal
- Psychotropic treatment in special patient groups
Psychotropic drug issues
- Failure to respond to treatment
- Discontinuation of treatment
- Drug concentration monitoring
- Psychomotor impairment
- Interactions with alcohol
- As required prescribing
- Competitive sport
Other therapies for psychiatric illness
- Psychological interventions
- Electroconvulsive therapy

Anxiety and associated disorders

Subsyndromal anxiety disorders
Adjustment disorder with anxious mood
Generalised anxiety disorder
Panic attack
Panic disorder
Obsessive compulsive disorder
Phobic disorders
- Agoraphobia
- Social anxiety disorder (social phobia)
- Specific phobias
Acute stress disorder
Post-traumatic stress disorder

Sleep disorders

Insomnia
Sleepiness
- Idiopathic hypersomnolence and narcolepsy
- Periodic limb movements of sleep/wakefulness and restless legs syndrome
Parasomnias
- Night terrors and somnambulism
- Nightmares and REM sleep behaviour disturbance
Jet lag

Mood disorders

Grief
Depression
- Subtypes of depression
- Assessing patients with depression
- Treatment of depression
- Anxiolytic or hypnotic co-prescription with antidepressants
- Changing from one antidepressant to another
- Failure to respond to adequate antidepressant therapy
- Antidepressant discontinuation
- Electroconvulsive therapy for depression
- Perinatal depression
- Recurrent depression
Bipolar disorder
- Acute treatment of bipolar disorder
- Prophylaxis for bipolar disorder
- Mixed episodes, dysphoric mania and rapid cycling bipolar disorder

Schizophrenia and related psychoses

Related psychoses
Principles of treatment
Treatment with antipsychotic drugs
Stages of treatment
Treatment of negative symptoms
Treatment-resistant schizophrenia
Electroconvulsive therapy for schizophrenia
Treatment of schizophrenia: practical prescribing points
- Changing from one antipsychotic to another
- Dosing strategies
- Co-prescription of other psychotropic drugs with antipsychotics
- Management of antipsychotic adverse effects

Behavioural emergencies

Delirium

Dementia

Substance use disorders

Alcohol abuse
Opioid abuse
Cannabis
Benzodiazepines, zolpidem and zopiclone
Stimulant abuse
- Amphetamine and cocaine overdose and toxicity
- ‘Ecstasy’ (MDMA, PMA) overdose and toxicity
- Stimulant discontinuation (withdrawal) syndrome
- Treatment of stimulant dependence
Hallucinogens
Ketamine
Gamma-hydroxybutyrate
Barbiturates
Inhalants
Anticholinergic drugs and antihistamines
Kava
Caffeine

Personality disorders

Eating disorders

Disorders usually first diagnosed in childhood and adolescence

Attention deficit hyperactivity disorder
Major depression
Anxiety disorders
- Obsessive compulsive disorder
- Separation anxiety disorder
- Generalised anxiety disorder
Pervasive developmental disorders, including autistic disorder
Intellectual disability with co-morbid mental disorder
Tourette syndrome
Juvenile bipolar disorder
Schizophrenia and other childhood psychoses
Disruptive behaviour disorders (including oppositional defiant disorder and conduct disorder)
Sleep disorders
Enuresis

Pregnancy and breastfeeding

Patient resources and support organisations

Sources of information and assistance

Clinical Institute Withdrawal of Alcohol Scale, revised (CIWA-Ar)

Electronic version

Therapeutic Guidelines: Psychotropic is available in electronic format as part of eTG complete.